While PD-L1 expression may be a reliable predictor of tumor response, a number of limitations, including the unstandardized cut-off value used to define positivity, the temporal and spatial heterogeneity of PD-L1 expression, and the complexity of the methods needed for analysis, hinder its wider use [42]. The gene discussed is CD274; the disease is neoplasm.